Bococizumab is a cutting-edge anti-PCSK9 antibody efficiently developed to combat hypercholesterolemia. It therapeutic agent interacts with the PCSK9 protein, a essential regulator of cholesterol amounts. By inhibiting https://theohweh364228.blognody.com/49081520/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia